The safety of electronic control devices (ECDs) has been questioned. This article reports 8 cases of TASER X26 ECD-induced loss of consciousness in which first recorded rhythms were ventricular tachycardia/fibrillation in 6 and asystole (after Ϸ30 minutes of nonresponsiveness) in 1. An external defibrillator reported a shockable rhythm in 1 case, but no recording was made. From an analysis of the cases and data from animal and clinical ECD studies, it is the opinion of the author that ECD stimulation can cause cardiac electrical capture and provoke cardiac arrest resulting from ventricular tachycardia/ventricular fibrillation. The cause is probably ventricular capture during the vulnerable period of the previous beat or ventricular capture at rates too fast for ventricular activation to remain organized. After prolonged ventricular tachycardia/ventricular fibrillation without resuscitation, asystole develops. The purpose of this article is not to condemn ECD use by trained professionals but to make ECD users aware that cardiac arrest caused by ventricular fibrillation can result from an ECD shock and to encourage users to be judicious concerning how and when to use the ECD weapon, to avoid chest shocks if possible, to monitor the person after an ECD shock, and to suspect this adverse response in any victim who loses consciousness. Users should be prepared to resuscitate, including deployment of an automated external defibrillator if indicated. See p 2417.
Risk Score for Predicting Long-Term Mortality After Coronary Artery Bypass Graft Surgery
Bedside friendly risk scores that predict in-hospital or 30-day mortality after coronary artery bypass graft (CABG) surgery are currently available. However, there is a need for a risk score that predicts long-term mortality after CABG surgery. In this study, we developed a Cox proportional hazards model that predicts mortality up to 7 years after CABG surgery using patient baseline risk factors. From this model, we created a simplified risk score that can accurately predict long-term mortality after CABG surgery. This risk score can be conveniently used to estimate long-term mortality after CABG surgery for a patient for whom CABG surgery is indicated; such information can also be useful while considering CABG surgery as an option to treat coronary artery disease. See p 2423.
On-Pump Versus Off-Pump Coronary Artery Bypass Surgery in Elderly Patients: Results From the Danish On-Pump Versus Off-Pump Randomization Study
Conventional coronary artery bypass grafting performed with the use of cardiopulmonary bypass is a well-validated treatment for patients with ischemic heart disease. Off-pump coronary artery bypass grafting (OPCAB) has been suggested to reduce the number of perioperative complications, especially in elderly patients. In a multicenter, randomized trial, we assigned 900 patients Ͼ70 years of age to conventional coronary artery bypass grafting or OPCAB surgery. The primary end point was to test the noninferiority of a composite end point of death, stroke, and myocardial infarction within 30 days postoperatively. According to the intention-to-treat analysis, statistically nonsignificant trends toward fewer perioperative strokes (2.2% versus 4.0%; Pϭ0.12) but more myocardial infarctions (8.2% versus 5.6%; Pϭ0.12) were seen in the OPCAB patients. The proportion of patients experiencing the combined end point within 30 days was 10.2% for conventional coronary artery bypass grafting and 10.7% for OPCAB. Hence, the noninferiority of OPCAB with the prespecified margin could not be confirmed. The mean number of grafts performed was significantly lower in the OPCAB group (2.9 versus 3.1; Pϭ0.005). At the 6-month follow-up, mortality was 4.2% in the OPCAB group versus 4.7% in the conventional coronary artery bypass grafting group (Pϭ0.75). Both groups showed significant improvement in selfassessed health-related quality of life after 6 months compared with preoperatively. We conclude that both conventional coronary artery bypass grafting and OPCAB are safe procedures improving quality of life when performed in elderly patients. No major differences in short-or intermediate-term outcomes were found. See p 2431.
Left Ventricular Longitudinal Function Predicts Life-Threatening Ventricular Arrhythmia and Death in Adults With Repaired Tetralogy of Fallot
Sudden cardiac death and life-threatening ventricular arrhythmia are a major concern in adults after repair of tetralogy of Fallot. Accurate risk stratification of patients who may benefit from implantable cardioverter-defibrillators would be crucial in this context. Previous studies have focused on the predictive value of surgical history, ECG parameters, inducible arrhythmia, exercise intolerance, and burden of myocardial fibrosis. More recently, left ventricular (LV) systolic dysfunction and diastolic dysfunction have been reported to carry prognostic information. Recent studies, however, suggest that longitudinal LV function, measured by speckle tracking echocardiography, is more sensitive in detecting early myocardial damage compared with LV ejection fraction. We assessed the relation between measures of LV longitudinal systolic function on speckle tracking (global LV strain) and on M-mode echocardiography (mitral annular plane systolic excursion) and outcome (sustained ventricular tachycardia, resuscitated sudden cardiac death, or appropriate implantable cardioverter-defibrillator discharge) in 413 tetralogy of Fallot patients (median follow-up, 2.9 years). On univariable Cox analysis, mitral annular plane systolic excursion and global LV strain were significantly related to the combined end point, whereas LV ejection fraction and echocardiographic estimates of LV diastolic dysfunction were not. An echocardiographic model was constructed using global LV strain or mitral annular plane systolic excursion, right ventricular fractional area change, and right atrial area, identifying tetralogy of Fallot patients with a higher risk of sudden cardiac death and life-threatening ventricular arrhythmias. The results of this study suggest that longitudinal measures of LV systolic function outperform LV ejection fraction in providing information on outcome and should be considered a useful adjunct to established markers such as QRS duration in the estimation of prognosis in this challenging population. See p 2440. 
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Prevalence of Kawasaki Disease in Young Adults With Suspected Myocardial Ischemia
Kawasaki disease (KD) is an acute, self-limited vasculitis of unknown origin that occurs most commonly in young children. Diagnosis depends on recognition of the clinical syndrome because no diagnostic test exists. Thus, the prevalence of individuals with missed KD is unknown. Up to 25% of patients with untreated KD and 5% of those treated with intravenous immunoglobulin will develop coronary artery aneurysms. Persistent aneurysms may remain silent until later in life when myocardial ischemia can occur. The impact of coronary aneurysms and coronary artery damage caused by KD and their prevalence among young adults presenting with symptoms of cardiac ischemia have not previously been studied. This study systematically evaluated a population of young adults undergoing coronary angiography at 4 hospitals in San Diego, CA, to estimate the prevalence of antecedent KD as a potential cause. We found that Ϸ5% of young adults who undergo coronary angiography to evaluate symptoms for myocardial ischemia may have coronary artery aneurysms with KD as the underlying cause. Thus, coronary sequelae of KD are responsible for a small but important percentage of young adults who present with myocardial ischemia. As more children with a history of KD reach adulthood, adult cardiologists are likely to see increasing numbers of patients with acute and subacute presentations of coronary sequelae of KD. Cardiologists should be aware of this special subset of patients who may benefit from medical and invasive management strategies that differ from those used to treat atherosclerotic coronary artery disease. See p 2447.
Cell Therapy in Chagas Cardiomyopathy (Chagas Arm of the Multicenter Randomized Trial of Cell Therapy in Cardiopathies Study): A Multicenter Randomized Trial
Heart failure is a common cause of death in patients with chronic chagasic cardiomyopathy. Current therapies are limited and, with the exception of heart transplantation, only delay disease progression. Cell therapy using bone marrow-derived cells has been a promising (albeit inconsistent) approach to the treatment of cardiovascular diseases. Experimental evidence in animal models and feasibility studies in patients with chronic chagasic cardiomyopathy have suggested that bone marrow mononuclear cell transplantation may improve cardiac function. This study reports the results of a multicenter, double-blind, randomized, placebo-controlled trial evaluating the efficacy of bone marrow mononuclear cells on left ventricular ejection fraction in 183 patients with chronic chagasic cardiomyopathy. Although both the placebo and cell-therapy groups showed a significant increase in left ventricular ejection fraction at 6 and 12 months of follow-up, this study failed to document a significant difference in change in left ventricular ejection fraction between the 2 groups. Intracoronary injection of bone marrow mononuclear cells was not associated with adverse clinical events. We conclude that with the methods used, no additional benefit of intracoronary mononuclear cell injection was found in patients with chronic chagasic cardiomyopathy and a left ventricular ejection fraction Ͻ35%. Nonetheless, cell-based therapies may still hold promise for chronic chagasic cardiomyopathy patients. Larger clinical trials focusing on hard clinical end points, new cell types, methods of delivery, dosage schemes, and disease stages are warranted to further test the efficacy of this novel therapeutic approach. See p 2454.
Blood Pressure Control Among US Veterans: A Large Multiyear Analysis of Blood Pressure Data From the Veterans Administration Health Data Repository
Despite the proven benefits of treatment of hypertension, control rates remained low in this country and around the world for many years. After the publication of the Veterans Affairs cooperative studies in the late 1960s and early 1970s that demonstrated a substantial reduction of cardiovascular complications with treatment of hypertension, efforts were put forth to identify and treat as many patients as possible. Concerted efforts and organized interventions have been orchestrated by many healthcare organizations to improve blood pressure control. The Healthy People 2010 initiative set and achieved a goal of Ն50% control of patients with hypertension. The Department of Veterans Affairs implemented a series of improvements in healthcare delivery in the late 1990s that included implementation of electronic medical records. The present study was designed to assess improvement of blood pressure control in 15 Veterans Administration Medical Centers across the United States from 2000 to 2010. Organized interventions that used the electronic medical record system, provider reminders, and enhancement of patient-provider interaction made it possible to improve blood pressure control steadily in the last 10 years. Blood pressure control rates improved from 46% in 2000 to 76% in 2010, a remarkable achievement. In some hospitals, control rates were as high as 85%. This improvement was realized across all ethnic and age groups and among both sexes. Preliminary analysis of results indicates substantial benefits on health outcomes. This study also found substantial seasonal differences in blood pressure control rates that may affect clinical outcomes. See p 2462.
Lipids and Lipoproteins and Risk of Different Vascular Events in the MRC/BHF Heart Protection Study
Low-density lipoprotein (LDL) cholesterol and high-density lipoprotein (HDL) cholesterol are established risk factors for vascular disease, but there is uncertainty as to whether measures of the numbers of LDL and HDL particles, rather than their cholesterol content, might be better predictors of risk. Small LDL particles are widely believed to be particularly hazardous, but the independent predictive value of lipoprotein subclasses is also unresolved. The present investigation considers the associations between baseline concentrations of cholesterol fractions, apolipoproteins B and A 1 , and lipoprotein particles assessed by nuclear magnetic resonance with vascular events during 5.3 years of follow-up among 20 000 high-risk individuals (2% average coronary event risk per year). Cholesterol and particle measures of LDL were strongly correlated and had similar predictive value for incident major occlusive coronary events and for arterial revascularization procedures. Given the total LDL particle number, the distribution between small and large particles did not add predictive value. Associations of these different LDL-related measures were much weaker or nonexistent with ischemic stroke and other cardiac events (mainly heart failure). After adjustment for LDL particle number, the predictive values of the cholesterol and particle measures of HDL for incident major occlusive coronary events were similar. In contrast, other cardiac events were strongly associated with fewer total and small HDL particles and larger mean HDL size but only very weakly associated with HDL cholesterol. The present results indicate that LDL lipoprotein particle measurements provide little additional predictive value over traditional measures for occlusive vascular events in a high-risk population. It is unclear whether the associations between HDL particle numbers and other cardiac events represent a causal or reverse-causal effect. See p 2469.
